WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

EVALUATION OF ANUVASANA BASTI AND AROHAN ANUVASANA BASTI IN JANU SANDHIGATA VATA (KNEE OSTEOARTHRITIS)

Dr. Priyanka*, Dr. Shivani Mahajan, Dr. Prabhat Kumar, Dr. Deepshikha

Abstract

Sandhigata Vata is the commonest form of articular disorder, it is type of Vata Vaydhi which is mainly occurs in Vriddavastha due to Dhatukshaya. Vata being the prime force responsible for the movement, it dominant in the later half life, the disease Janu Sandhigata Vata will manifest due to Dhatu Kshya, Prakupita Vata will dry up the Sandhisthita Shleskaka Kapha resulting in Sandhishool (joint pain), Ankunchan PrasarnayoShoola, Shotha, Graham, Sandhi Atopa, and Sandhi Shaithilya. Sandhigata Vata can be correlated with Osteoarthritis in modern medical science because it also produces the features such as pain, inflammation, stiffness, limited movements and deformity in serve cases. Janu Sandhigata Vata can be compared with knee Osteoarthritis of contemporary medical science. Basti Karma having multidimentional action is the best suited Panchkarma to overcome the morbid Vata Doshas, known as „Ardha Chikitsa.’ As Pakwashaya is said to be the main seat of Vata Dosha. Anuvasana Basti is the simple and easiest method of administration of Sneha which expels the vitiated Doshas as well as it nourishes the body by swift action and high efficacy. Hence present open labelled clinical study randomly total 40 patients having symptoms of Janu Sandhiagata Vata were selected, they were divided into two groups, group A received Anuvassana Basti of Ksirbala Taila (144 ml) daily for 9 days and group B received Arohana Anuvasana Basti of Ksirbala Taila in increasing dose starting with (48ml, increasing 12 ml each day and 144 ml on 9th day). And hence to compare their effects in relieving signs and symptoms of the disease.

Keywords: .


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More